Management of MRSA Boils

Initial Management Approach

Incision and drainage alone is likely adequate for simple boils or abscesses caused by MRSA, according to the Infectious Diseases Society of America 1, 2
Antibiotic therapy should be added to incision and drainage when the following conditions are present: severe or extensive disease with associated cellulitis, signs of systemic illness, immunosuppression or significant comorbidities, extremes of age, abscess in difficult-to-drain areas, associated septic phlebitis, or lack of response to incision and drainage alone, as recommended by the Infectious Diseases Society of America 1, 2, 3

The American College of Physicians recommends trimethoprim-sulfamethoxazole (TMP-SMX) as the preferred antibiotic for MRSA boils, with a dosage of 1-2 double-strength tablets orally twice daily, due to its high effectiveness based on clinical evidence 1, 2, 4
Doxycycline and minocycline are alternative options, with dosages of 100 mg orally twice daily and 200 mg initially, then 100 mg orally twice daily, respectively, although they are contraindicated in children under 8 years and pregnancy, as noted by the Infectious Diseases Society of America 1, 2
Clindamycin provides coverage for both MRSA and beta-hemolytic streptococci, but has a higher risk of Clostridioides difficile infection and should be avoided if high rates of clindamycin resistance in local MRSA strains, according to the World Health Organization 2, 4

The World Health Organization recommends 7-14 days of antibiotic therapy, which should be individualized based on clinical response, and treatment should be guided by culture results to confirm MRSA and guide definitive therapy 4, 5

Vancomycin is recommended at a dosage of 15-20 mg/kg/dose IV every 8-12 hours, while linezolid and daptomycin are alternative options, according to the Infectious Diseases Society of America 1, 3

Failing to perform adequate incision and drainage is a common pitfall, as it is the cornerstone of treatment, and using beta-lactam antibiotics alone is ineffective against MRSA, as noted by the American College of Physicians 1, 2
Using rifampin as monotherapy or adjunctive therapy for skin infections can lead to resistance, according to the Centers for Disease Control and Prevention 2

Keeping draining wounds covered with clean, dry bandages, maintaining good personal hygiene with regular handwashing, and focusing cleaning on high-touch surfaces can help reduce the risk of MRSA recurrence, as recommended by the Centers for Disease Control and Prevention 5